Colorectal Cancer Clinical Trials

Clinical Trial: Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba

Clinical Trial: Colorectal Cancer Detection by Means of Optical Fluoroscopy

Clinical Trial: Longitudinal Study of Symptoms in Colorectal Cancer

Clinical Trial: Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

Clinical Trial: Cytokine Changes After Colorectal Cancer Resection

Clinical Trial: Sentinel Concept in Early Stage Cervical Cancer

Clinical Trial: Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer or Polyposis Syndrome or Who Are at High Risk of Developing Hereditary Colorectal Cancer

Clinical Trial: Trial of Aspirin and Arginine Restriction in Colorectal Cancer

Clinical Trial: Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

Clinical Trial: Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy

Clinical Trial: MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

Clinical Trials: Study of Pegfilgrastim Administered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab and Either FOLFOX or FOLFIRI

Clinical Trials: A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay

Clinical Trials: A Randomized, Multicenter, Phase 2 Study to Compare the Efficacy of Panitumumab in Combination With mFOLFOX6 to the Efficacy of Bevacizumab in Combination With mFOLFOX6 in Patients With Previously Untreated, KRAS Wild-Type, Unresectable, M

Clinical Trial: Screening for Familial Colorectal Cancer (CRC) Patients

For a complete listing of clinical trials pertaining to Colorectal Cancer via ClinicalTrials.gov, click here.

Colorectal Cancer News

Experimental agent slows progression of colorectal cancer

Not Enough Americans Being Screened for Cancer

Study demonstrates mortality disparity among colorectal cancer patients

ACS annual report says cancer mortality is decreasing

New Predictors of Treatment Response Identified for CRC

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions